시장보고서
상품코드
1150058

세계의 모노클로널 항체 시장 점유율, 규모, 동향, 산업 분석 리포트 : 소스 유형별, 생산 유형별, 용도별, 최종사용자별, 지역별, 부문 예측(2022-2030년)

Monoclonal Antibodies Market Share, Size, Trends, Industry Analysis Report, Source Type (Chimeric, Murine, Humanized, Human); By Production Type (In Vivo, In Vitro); By Application; By End-use; By Region; Segment Forecast, 2022 - 2030

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 119 Pages | 배송안내 : 1-2일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 모노클로널 항체 시장 규모는 2030년까지 4,791억 3,000만 달러에 달할 것으로 예측되고 있습니다.

세계의 모노클로널 항체 시장에 대해 조사분석했으며, 시장 역학, 부문 분석, 지역 분석, 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

  • 리포트 설명
    • 조사 목적
    • 시장 범위
    • 전제조건
  • 이해관계자

제2장 주요 요약

  • 시장 하이라이트

제3장 조사 방법

  • 개요
    • 데이터 마이닝
  • 데이터 소스
    • 1차 소스
    • 2차 소스

제4장 세계의 모노클로널 항체 시장 인사이트

  • 모노클로널 항체 : 업계의 스냅숏
  • 모노클로널 항체 시장 역학
    • 촉진요인과 기회
    • 억제요인과 과제
  • Porter's Five Forces 분석
    • 공급 기업의 교섭력(중)
    • 신규 참여업체의 위협(저)
    • 구매자의 교섭력(중)
    • 대체품의 위협(중)
    • 기존 기업간 경쟁력(고)
  • PESTLE 분석
  • 모노클로널 항체 업계의 동향
  • 밸류체인 분석
  • COVID-19 영향 분석

제5장 세계의 모노클로널 항체 시장 : 소스 유형별

  • 주요 조사 결과
  • 서론
    • 소스 유형별 : 2018-2030년
  • 마우스
    • 마우스별, 지역별 : 2018-2030년
  • 키메라
    • 키메라별, 지역별 : 2018-2030년
  • 인간화
    • 인간화별, 지역별 : 2018-2030년
  • 인간
    • 인간별, 지역별 : 2018-2030년

제6장 세계의 모노클로널 항체 시장 : 생산 유형별

  • 주요 조사 결과
  • 서론
    • 생산 유형별 : 2018-2030년
  • 인비보
    • 인비보별, 지역별 : 2018-2030년
  • 인비트로
    • 인비트로별, 지역별 : 2018-2030년

제7장 세계의 모노클로널 항체 시장 : 용도별

  • 주요 조사 결과
  • 서론
    • 용도별 : 2018-2030년
  • 종양학
    • 종양학별, 지역별 : 2018-2030년
  • 자가면역질환
    • 자가면역질환별, 지역별 : 2018-2030년
  • 감염증
    • 감염증별, 지역별 : 2018-2030년
  • 신경질환
    • 신경질환별, 지역별 : 2018-2030년
  • 기타
    • 기타별, 지역별 : 2018-2030년

제8장 세계의 모노클로널 항체 시장 : 최종사용자별

  • 주요 조사 결과
  • 서론
    • 최종사용자별 : 2018-2030년
  • 병원
    • 병원별, 지역별 : 2018-2030년
  • 전문 센터
    • 전문 센터별, 지역별 : 2018-2030년
  • 기타
    • 기타별, 지역별 : 2018-2030년

제9장 세계의 모노클로널 항체 시장 : 지역별

  • 주요 조사 결과
  • 서론
    • 모노클로널 항체 시장 평가 - 지역별 : 2018-2030년
  • 북미
    • 소스 유형별 : 2018-2030년
    • 최종사용자별 : 2018-2030년
    • 생산 유형별 : 2018-2030년
    • 용도별 : 2018-2030년
    • 미국
    • 캐나다
  • 유럽
    • 소스 유형별 : 2018-2030년
    • 최종사용자별 : 2018-2030년
    • 생산 유형별 : 2018-2030년
    • 용도별 : 2018-2030년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
  • 아시아태평양
    • 소스 유형별 : 2018-2030년
    • 최종사용자별 : 2018-2030년
    • 생산 유형별 : 2018-2030년
    • 용도별 : 2018-2030년
    • 중국
    • 인도
    • 일본
    • 말레이시아
    • 인도네시아
    • 한국
  • 중동·아프리카
    • 소스 유형별 : 2018-2030년
    • 최종사용자별 : 2018-2030년
    • 생산 유형별 : 2018-2030년
    • 용도별 : 2018-2030년
    • 사우디아라비아
    • 남아프리카공화국
    • 이스라엘
    • 아랍에미리트
  • 라틴아메리카
    • 소스 유형별 : 2018-2030년
    • 최종사용자별 : 2018-2030년
    • 생산 유형별 : 2018-2030년
    • 용도별 : 2018-2030년
    • 멕시코
    • 브라질
    • 아르헨티나

제10장 경쟁 구도

  • 사업 확장과 인수 분석
    • 사업 확장
    • 인수
  • 제휴/협업/협정/전시회

제11장 기업 개요

  • Abbott Laboratories
  • Amgen Inc
  • AstraZeneca plc
  • Bayer AG
  • Biogen Inc.
  • Bristol Myers Squibb
  • Daiichi Sankyo Company Limited
  • Eli Lilly and Company
  • F. Hoffman-La Roche Ltd.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Merck KGaA
  • Novo Nordisk A/S
  • Novartis
  • Pfizer Inc
  • Sanofi S.A.
  • Thermo Fisher Scientific, Inc.
  • Viatris Inc.
KSA 22.11.18

The global Monoclonal Antibodies market size is expected to reach USD 479.13 billion by 2030, according to a new study by Polaris Market Research. The report "Monoclonal Antibodies Market Share, Size, Trends, Industry Analysis Report, By Source Type (Chimeric, Murine, Humanized, Human), By Production Type (In Vivo, In Vitro), By Application, By End-use, By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides an analysis of future market growth.

The increasing uses of mAb therapies, rising government initiatives in infection control and management, and growing cancer incidences, with the demand for cost-effective biosimilar monoclonal antibodies, are the major factors driving the market. In addition, the high demand for biologics, the expansion of genomics R&D activities, and the introduction of technologically advanced genetic platforms like next-generation sequencing also spur market growth.

Furthermore, the monoclonal antibody market has grown due to the COVID-19 virus outbreak. Effective treatments are required due to the sudden increase in individuals with COVID-19 and the mortality risk associated with the illness. Additionally, due to their potential to reduce disease burden, numerous industry participants are consistently working to create novel mAb for the prevention and treatment of the COVID-19 virus. These antibodies are an efficient alternative for decreasing COVID-19, and the US FDA has given emergency use authorizations (EUA) for several of these antibodies.

Monoclonal Antibodies Market Report Highlights

In 2021, the human source category segment had the most significant proportion. Human monoclonal antibody product approvals and an increase in medicine launches contribute to the segment's growth. The market for this segment is predicted to grow due to human mAb in treating numerous infectious diseases.

The low levels of contamination provided by the method and the availability of improved biomanufacturing capabilities made in vitro production type the dominant type in 2021.

Due to the increasing number of mAb cancer therapies that have received approval, as well as growing public and scientific knowledge of these treatments, the oncology segment held the majority of the market in 2021.

Use of monoclonal antibodies for cancer treatment in hospitals and rising healthcare spending that favors the adoption of such medicines, hospitals made up the highest proportion of the end-use segment in 2021.

North America held the largest market share owing to Increasing Industry R&D spending and government financing for cancer research, which have aided in developing innovative monoclonal antibody treatments.

Major players operating in the industry include Abbott Laboratories, Amgen Inc, AstraZeneca plc, Bayer AG, Biogen Inc., Bristol Myers Squibb, Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novo Nordisk A/S, Pfizer Inc, Sanofi S.A., Thermo Fisher Scientific, Inc.,and Viatris Inc.

Polaris Market Research has segmented the Monoclonal Antibodies Market report based on raw material, type, technology, end-use, and region:

Monoclonal Antibodies, Source type Outlook (Revenue - USD Billion, 2018 - 2030)

Murine

Chimeric

Humanized

Human

Monoclonal Antibodies, Production Type Outlook (Revenue - USD Billion, 2018 - 2030)

In Vivo

In Vitro

Monoclonal Antibodies Application Outlook (Revenue - USD Billion, 2018 - 2030)

Oncology

Autoimmune Diseases

Infectious Diseases

Neurological Diseases

Others

Monoclonal Antibodies, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Hospitals

Specialty Centers

Others

Monoclonal Antibodies, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Monoclonal Antibodies Market Insights

  • 4.1. Monoclonal Antibodies - Industry Snapshot
  • 4.2. Monoclonal Antibodies Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Incidences Of Chronic Diseases
      • 4.2.1.2. Technological Advancements
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost Of Therapeutic Mabs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Monoclonal Antibodies Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Monoclonal Antibodies Market, by Source Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
  • 5.3. Murine
    • 5.3.1. Global Monoclonal Antibodies Market, by Murine, by Region, 2018 - 2030 (USD Billion)
  • 5.4. Chimeric
    • 5.4.1. Global Monoclonal Antibodies Market, by Chimeric, by Region, 2018 - 2030 (USD Billion)
  • 5.5. Humanized
    • 5.5.1. Global Monoclonal Antibodies Market, by Humanized, by Region, 2018 - 2030 (USD Billion)
  • 5.6. Human
    • 5.6.1. Global Monoclonal Antibodies Market, by Human, by Region, 2018 - 2030 (USD Billion)

6. Global Monoclonal Antibodies Market, by Production Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
  • 6.3. In Vivo
    • 6.3.1. Global Monoclonal Antibodies Market, by In Vivo, by Region, 2018 - 2030 (USD Billion)
  • 6.4. In Vitro
    • 6.4.1. Global Monoclonal Antibodies Market, by In Vitro, by Region, 2018 - 2030 (USD Billion)

7. Global Monoclonal Antibodies Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
  • 7.3. Oncology
    • 7.3.1. Global Monoclonal Antibodies Market, by Oncology, by Region, 2018 - 2030 (USD Billion)
  • 7.4. Autoimmune Diseases
    • 7.4.1. Global Monoclonal Antibodies Market, by Autoimmune Diseases, by Region, 2018 - 2030 (USD Billion)
  • 7.5. Infectious Diseases
    • 7.5.1. Global Monoclonal Antibodies Market, by Infectious Diseases, by Region, 2018 - 2030 (USD Billion)
  • 7.6. Neurological Diseases
    • 7.6.1. Global Monoclonal Antibodies Market, by Neurological Diseases, by Region, 2018 - 2030 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Monoclonal Antibodies Market, by Others, by Region, 2018 - 2030 (USD Billion)

8. Global Monoclonal Antibodies Market, by End-Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
  • 8.3. Hospitals
    • 8.3.1. Global Monoclonal Antibodies Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
  • 8.4. Speciality Centres
    • 8.4.1. Global Monoclonal Antibodies Market, by Speciality Centres, by Region, 2018 - 2030 (USD Billion)
  • 8.5. Others
    • 8.5.1. Global Monoclonal Antibodies Market, by Others, by Region, 2018 - 2030 (USD Billion)

9. Global Monoclonal Antibodies Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Monoclonal Antibodies Market Assessment, By Geography, 2018 - 2030 (USD Billion)
  • 9.3. Monoclonal Antibodies Market - North America
    • 9.3.1. North America: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
    • 9.3.2. North America: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.3.3. North America: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
    • 9.3.4. North America: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.3.5. Monoclonal Antibodies Market - U.S.
      • 9.3.5.1. U.S.: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.3.5.2. U.S.: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.3.5.3. U.S.: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.3.5.4. U.S.: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.3.6. Monoclonal Antibodies Market - Canada
      • 9.3.6.1. Canada: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.3.6.2. Canada: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.3.6.3. Canada: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.3.6.4. Canada: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
  • 9.4. Monoclonal Antibodies Market - Europe
    • 9.4.1. Europe: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
    • 9.4.2. Europe: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.4.3. Europe: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
    • 9.4.4. Europe: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.5. Monoclonal Antibodies Market - UK
      • 9.4.5.1. UK: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.4.5.2. UK: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.4.5.3. UK: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.4.5.4. UK: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.6. Monoclonal Antibodies Market - France
      • 9.4.6.1. France: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.4.6.2. France: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.4.6.3. France: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.4.6.4. France: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.7. Monoclonal Antibodies Market - Germany
      • 9.4.7.1. Germany: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.4.7.2. Germany: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.4.7.3. Germany: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.4.7.4. Germany: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.8. Monoclonal Antibodies Market - Italy
      • 9.4.8.1. Italy: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.4.8.2. Italy: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.4.8.3. Italy: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.4.8.4. Italy: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.9. Monoclonal Antibodies Market - Spain
      • 9.4.9.1. Spain: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.4.9.2. Spain: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.4.9.3. Spain: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.4.9.4. Spain: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.10. Monoclonal Antibodies Market - Netherlands
      • 9.4.10.1. Netherlands: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.4.10.2. Netherlands: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.4.10.3. Netherlands: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.4.10.4. Netherlands: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.4.11. Monoclonal Antibodies Market - Russia
      • 9.4.11.1. Russia: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.4.11.2. Russia.: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.4.11.3. Russia: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.4.11.4. Russia: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
  • 9.5. Monoclonal Antibodies Market - Asia Pacific
    • 9.5.1. Asia Pacific: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
    • 9.5.2. Asia Pacific: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.5.3. Asia Pacific: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
    • 9.5.4. Asia Pacific: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.5. Monoclonal Antibodies Market - China
      • 9.5.5.1. China: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.5.5.2. China.: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.5.5.3. China: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.5.5.4. China: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.6. Monoclonal Antibodies Market - India
      • 9.5.6.1. India: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.5.6.2. India.: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.5.6.3. India: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.5.6.4. India: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.7. Monoclonal Antibodies Market - Japan
      • 9.5.7.1. Japan: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.5.7.2. Japan.: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.5.7.3. Japan: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.5.7.4. Japan: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.8. Monoclonal Antibodies Market - Malaysia
      • 9.5.8.1. Malaysia: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.5.8.2. Malaysia.: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.5.8.3. Malaysia: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.5.8.4. Malaysia: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.9. Monoclonal Antibodies Market - Indonesia
      • 9.5.9.1. Indonesia: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.5.9.2. Indonesia.: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.5.9.3. Indonesia: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.5.9.4. Indonesia: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.5.10. Monoclonal Antibodies Market - South Korea
      • 9.5.10.1. South Korea: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.5.10.2. South Korea.: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.5.10.3. South Korea: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.5.10.4. South Korea: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
  • 9.6. Monoclonal Antibodies Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
    • 9.6.2. Middle East & Africa: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.6.3. Middle East & Africa: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
    • 9.6.4. Middle East & Africa: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.6.5. Monoclonal Antibodies Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.6.5.2. Saudi Arabia: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.6.5.3. Saudi Arabia: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.6.5.4. Saudi Arabia: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.6.6. Monoclonal Antibodies Market - South Africa
      • 9.6.6.1. South Africa: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.6.6.2. South Africa: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.6.6.3. South Africa: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.6.6.4. South Africa: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.6.7. Monoclonal Antibodies Market - Israel
      • 9.6.7.1. Israel: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.6.7.2. Israel: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.6.7.3. Israel: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.6.7.4. Israel: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.6.8. Monoclonal Antibodies Market - UAE
      • 9.6.8.1. UAE: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.6.8.2. UAE: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.6.8.3. UAE: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.6.8.4. UAE: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
  • 9.7. Monoclonal Antibodies Market - Latin America
    • 9.7.1. Latin America: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
    • 9.7.2. Latin America: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
    • 9.7.3. Latin America: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
    • 9.7.4. Latin America: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.7.5. Monoclonal Antibodies Market - Mexico
      • 9.7.5.1. Mexico: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.7.5.2. Mexico: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.7.5.3. Mexico: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.7.5.4. Mexico: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.7.6. Monoclonal Antibodies Market - Brazil
      • 9.7.6.1. Brazil: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.7.6.2. Brazil: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.7.6.3. Brazil: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.7.6.4. Brazil: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)
    • 9.7.7. Monoclonal Antibodies Market - Argentina
      • 9.7.7.1. Argentina: Monoclonal Antibodies Market, by Source Type, 2018 - 2030 (USD Billion)
      • 9.7.7.2. Argentina: Monoclonal Antibodies Market, by End-Use, 2018 - 2030 (USD Billion)
      • 9.7.7.3. Argentina: Monoclonal Antibodies Market, by Production Type, 2018 - 2030 (USD Billion)
      • 9.7.7.4. Argentina: Monoclonal Antibodies Market, by Application, 2018 - 2030 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abbott Laboratories
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Amgen Inc
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. AstraZeneca plc
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Bayer AG
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Biogen Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Bristol Myers Squibb
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Daiichi Sankyo Company Limited
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Eli Lilly and Company
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. F. Hoffman-La Roche Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. GlaxoSmithKline plc
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Johnson & Johnson Services, Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Merck & Co., Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Merck KGaA
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Novo Nordisk A/S
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Novartis
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Pfizer Inc
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development
  • 11.17. Sanofi S.A.
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Benchmarking
    • 11.17.4. Recent Development
  • 11.18. Thermo Fisher Scientific, Inc.
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Benchmarking
    • 11.18.4. Recent Development
  • 11.19. Viatris Inc.
    • 11.19.1. Company Overview
    • 11.19.2. Financial Performance
    • 11.19.3. Product Benchmarking
    • 11.19.4. Recent Development
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제